Sociedad Española de Terapia Génica y Celular
  • Home
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
Home

This week in gene and cell therapy - 22 June 2018

Gene and cell therapy headlines 15 - 22 June

bluebird bio presents data from Phase 1/2 trial of LentiGlobin gene therapy for thalassemia and prepares for registration in Europe

Chiesi granted FDA orphan drug designation for GPLSCD01 cell therapy for limbal stem cell deficiency (LSCD)

Cellectis joins movement towards off the shelf CAR-T cell therapies

Sarepta phase 1/2 trial of gene therapy for Duchenne muscular dystrophy shows promising early results

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2023 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us